Seti i të dhënave

• ReLife study quality of life questionnaire

  The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery.

• ReLife study general questionnaire

  Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months...

• UroLife study quality of life questionnaire

  The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis.

• ReLife study abdominal CT scans

  Abdominal CT scans are availabe for n=349 patients.

• UroLife study molecular subtypes

  Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours.

• PRIDE Study medication diaries

  6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants...

• PRIDE Study paternal questionnaire data

  Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate.

• PRIDE Study blood samples

  First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C.

• PRIDE Study saliva samples

  Single saliva samples for cortisol analyses collected in 2012-2020 in subgroup (N~3400). Partially analyzed, remaining samples stored at -20°C.

• BioCAPTURE registry data

  In this ongoing prospective cohort study containing data of 24 Dutch hospitals, patients with psoriasis are asked to be included for the BioCAPTURE registry at the moment of...

• UroLife study clinical data

  Data on tumour characteristics, treatment, and recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer Registry...

• ReLife study accelerometer data

  Accelerometer data (ActivPal) is available at 3 (n=346), 12 (n=323) and 24 months (n=271) after surgery.

• PRIDE Study pharmacy data

  Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional...

• POM biomaterials

  Biomaterials of the Personalized Parkinson Project, including blood, CSF and stool samples.

• PRIDE-BIOME project

  Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of...

• PRIDE Study nutrition

  Food frequency questionnaire administered in early pregnancy, assessing multiple macronutrients and micronutrients.

• PRISMA Imaging data

  The PRISMA imaging data consists of both processed and unprocessed screening mammograms (two views of each breast for each participant) obtained at study entry.